Lung Cancer

Top Story

AACR president: ‘Full spectrum’ of cancer research must remain priority

AACR president: ‘Full spectrum’ of cancer research must remain priority
June 29, 2016

Nancy E. Davidson, MD, director of University of Pittsburgh Cancer Institute, took over as president of the American Association for Cancer Research this spring.

Davidson — an active member of AACR since 1988 — specializes in clinical and translational breast cancer research, cancer biology and treatment, and the role of apoptosis and mechanisms of epigenetic regulation of gene expression of the ER-alpha gene in breast cancer treatment.

FDA’s cancer drug director to lead Oncology Center of Excellence

June 29, 2016
Richard Pazdur, MD, director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation, has been named acting director of the…

Ipilimumab, nivolumab linked with increased risk of autoimmune joint, tissue diseases in cancer patients

June 28, 2016
Patients with cancer treated with ipilimumab or nivolumab alone or in combination with each other experienced a higher than normal risk of developing autoimmune joint…
In the JournalsPerspective

Video-assisted thoracoscopic surgery for NSCLC reduces pain, improves quality of life

June 28, 2016
Patients with stage I non–small cell lung cancer who underwent video-assisted thoracoscopic surgery experienced less postoperative pain and better quality of life…
CME Video

Updates in Immunotherapy – Philadelphia 2015

This activity is supported by an educational grant from Merck & Co., Inc.

The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval…
More »
Video
Meeting News Coverage

VIDEO: Expert discusses controversies in lung cancer screenings

May 13, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »

AACR president: ‘Full spectrum’ of cancer research must remain priority

June 29, 2016
Nancy E. Davidson, MD, director of University of Pittsburgh Cancer Institute, took over as president of the American Association for Cancer Research…

FDA’s cancer drug director to lead Oncology Center of Excellence

June 29, 2016
Richard Pazdur, MD, director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation, has been named acting…

Ipilimumab, nivolumab linked with increased risk of autoimmune joint, tissue diseases in cancer patients

June 28, 2016
Patients with cancer treated with ipilimumab or nivolumab alone or in combination with each other experienced a higher than normal risk of developing…

In the JournalsPerspective

Video-assisted thoracoscopic surgery for NSCLC reduces pain, improves quality of life

June 28, 2016
Patients with stage I non–small cell lung cancer who underwent video-assisted thoracoscopic surgery experienced less postoperative pain and…

Eight updates about how lifestyle affects cancer risk, outcomes

June 27, 2016
Lifestyle choices can contribute considerably to a person’s cancer risk, as well the outcomes they achieve after they are diagnosed with a…

In the Journals

Pembrolizumab shows activity in brain metastases from NSCLC, melanoma

June 24, 2016
Pembrolizumab demonstrated therapeutic activity in brain metastases of patients with non–small cell lung cancer or melanoma, according to early…

At IssueVideo

VIDEO: Toxicities related to immune therapies ‘unpredictable’ but ‘manageable’

June 23, 2016
James P. Allison, PhD, chair of the department of immunology and executive director of the immunotherapy platform at MD Anderson Cancer Center in…

Meeting News CoverageVideo

VIDEO: Merge of immunotherapy, genomics lead to personalized treatment

June 23, 2016
CHICAGO — Candace Johnson, PhD, president and CEO of Roswell Park Cancer Institute, discusses how research in immunotherapy and genomics can…

Meeting News CoverageVideo

VIDEO: Diabetes, obesity associated with chemotherapy-induced neuropathy

June 22, 2016
CHICAGO — Dawn L. Hershman, MD, MS, associate professor of medicine at Columbia University Medical Center, reviews study results that…

In the Journals

Dabrafenib plus trametinib shows promise for BRAF–mutated NSCLC

June 21, 2016
Combined treatment with dabrafenib and trametinib demonstrated robust antitumor activity and tolerable safety for patients with…

More Headlines »
morganatic-roan
morganatic-roan